検索結果

adquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug designation to the in-house developed compound having the development code SJP-0008 ...

Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

lives of the public, thereby contributing to the improvement of the lives and health of all people around the world. To abide by the principles defined above, SENJU declares the following in order to...

Business Activities | About Senju | SENJU Pharmaceutical

Based on a sense of mission to contribute to the health of the eyes of people around the world, and a development policy that puts top priority on safety, we have always taken a pioneering path in oph...

Medical devices and healthcare | Business Activities | About Senju | SENJU Pharmaceutical

tribute to the maintenance and improvement of “pleasure to see” Quality of Vision (QOV) of patients around the world. Senju Pharmaceutical has taken on the challenge of forming the Vision Care Platfor...

CEO Message | About Senju | SENJU Pharmaceutical

e trusted by society as we contribute to the support and improvement of patients’ Quality of Vision around the world by continuously creating and proposing revolutionary medical products and services....